FVII or FVIIa variants

Details for Australian Patent Application No. 2004221761 (hide)

Owner Bayer HealthCare LLC

Inventors Glazer, Steven; Ropke, Mads; Andersen, Kim Vilbour; Haaning, Jesper Mortensen

Agent Spruson & Ferguson

Pub. Number AU-B-2004221761

PCT Pub. Number WO2004/083361

Priority 60/479,708 19.06.03 US; 60/456,547 20.03.03 US

Filing date 22 March 2004

Wipo publication date 30 September 2004

Acceptance publication date 7 January 2010

International Classifications

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

A61K 38/48 (2006.01) Medicinal preparations containing peptides

C12N 15/57 (2006.01) Mutation or genetic engineering - acting on peptide bonds (3.4)

Event Publications

8 September 2005 PCT application entered the National Phase

  PCT publication WO2004/083361 Priority application(s): WO2004/083361

13 November 2008 Assignment before Grant

  Maxygen Holdings Ltd. The application has been assigned to Bayer HealthCare LLC

7 January 2010 Application Accepted

  Published as AU-B-2004221761

6 May 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004221787-Method of disk attachment to cast wheel

2004221760-Short interfering RNA (siRNA) analogues